Zion Market Research has published a new report titled “Glycomics/Glycobiology Market by Product (enzymes, kits, reagents and instruments), application (Drug Discovery & Development, Diagnostics and Others), Diagnosis (blood testing, genetic testing, pre-implantation genetic diagnosis (PGD) and others), End user (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies and CROs): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025”.
According to the report, global demand for Glycomics/Glycobiology market was valued at approximately USD 910.08 million in 2018, and is expected to generate revenue of around USD 2,361.66 million by end of 2025, growing at a CAGR of around 14.64% between 2019 and 2025.
Request Free Sample Report of Keyword @ https://www.zionmarketresearch.com/sample/glycomics-glycobiology-industry
Glycobiology is the study of the structure, function and biology of carbohydrates, also known as glycans. There are glycans in every living organism. Glycobiology is a rapidly growing area of interest in biomedicine, biotechnology, and basic research. Most proteins in eukaryotic cells are modified post-translationally. Glycans attachment, or “glycosylation,” is one of the most common cell viability modifications. There are two forms of glycosylation: N-linked (glycan attached to asparagine) and O-linked (glycan attached to serine or threonine).
Increasing drug discovery and production leads to an increase in R&D spending by biotech companies. Consequently, there is a growing need for glycomics research techniques to perform a comprehensive study of glycomes. Increasing the number of government initiatives to raise R&D funding has contributed to an increasing need for glycomics techniques. These funding steps are expected to improve demand in the near future for glycomics research techniques. Key businesses also pursue comprehensive R&D programs in order to develop innovative and technologically advanced products.
Download Free PDF Research Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/glycomics-glycobiology-industry
The market for Glycomics/Glycobiology is segmented based on product, application, end-user and region. Based on product, the market is segmented into enzymes, kits, reagents and instruments. Because of its wide range of research & diagnostic applications and the repeated purchasing of these products, enzymes are expected to be the fastest growing segment on the global Glycomics / Glycobiology market. The market is divided into Drug Discovery & Development, Diagnostics and Others based on application. Drug discovery & production accounted for the largest revenue share in 2018 and focused on the development of new drugs due to high demand for personalized medicines.
Based on end user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies and CROs. In 2018, academic and scientific institutes accounted for the largest share of income due to increased spending on R&D. Cooperation between major organizations and research institutes further facilitates the expansion of the field. Due to increased R&D investment in drug research, research and development, and further glycobiology research, the segment of pharmaceutical and biotechnology is expected to report the highest CAGR during the preliminary period.
To view TOC of this report request here@ https://www.zionmarketresearch.com/toc/glycomics-glycobiology-industry
Regional segmentation comprises the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further segmented into major countries such as US, Canada, Germany, UK, France, China, Japan, India, GCC countries, Brazil. In 2018, North America dominated the global market for glycomics / glycobiology and is expected to continue to lead over the forecast period. North America’s key driver of the regional market is the involvement of a large number of research laboratories and pharmaceutical and biotechnology firms.
Some of the players included in Glycomics/Glycobiology market are Agilent Technologies, Bruker, Danaher, Merck KGaA, New England Biolabs, ProZyme, Shimadzu Corporation, Takara Bio, Inc., ThermoFisher Scientific, Inc., and Waters Corporation amongst others.
The report segments global Glycomics/Glycobiology market as follows:
Global Glycomics/Glycobiology Market: Product Segment Analysis
- Glycan Labeling Kits
- Glycan Purification Kits
- Glycan Release Kits
- Mass Spectrometers
- Array Systems
Global Glycomics/Glycobiology Market: Application Segment Analysis
- Drug Discovery & Development
Global Glycomics/Glycobiology Market: End-user Segment Analysis
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Global Glycomics/Glycobiology Market: Regional Segment Analysis
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651